BCAL Diagnostics (ASX:BDX) and Precion partner for breast cancer product development
BCAL Diagnostics (BDX) signs an agreement with US company Precion to further…
Fri, 03 May | Close | Change |
4:24pm | 7,629.0 | 42.0 |
Closed at Sat, 04 May 6:31pm |
S&P/ASX Sm. Ords. | 3,001.9 | 25.6 | 0.86% |
All Ordinaries | 7,897.5 | 48.1 | 0.61% |
S&P/ASX 100 | 6,402.0 | 33.6 | 0.53% |
RCR | RINCON RESOURCES LIMITED | 14.5¢ | 52.6% |
CGR | CGN RESOURCES LIMITED | 41.5¢ | 29.7% |
OSX | OSTEOPORE LIMITED | 37.5¢ | 25.0% |
1TT | THRIVE TRIBE TECHNOLOGIES LIMITED | 0.8¢ | 42.9% |
FZR | FITZROY RIVER CORPORATION LTD | 11.5¢ | 28.1% |
TZL | TZ LIMITED | 1.9¢ | 24.0% |